Inventor · disambiguated record
Feng Cong
Also filed as: CONG FENG
9 granted patents·9 pending applications·36 citations·filing 2007–2020
85Inventor score
Top patents by PatentIndex Score
18 records- 0188US9290573B2Therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodiesCONG FENG·Filed 2011·Granted Mar 22, 2016·16 cites·9 claims
- 0286US9862764B2Compositions and methods for antibodies targeting BMP6CONG FENG·Filed 2015·Granted Jan 9, 2018·8 cites·54 claims
- 0382US10683346B2Compositions and methods for antibodies targeting BMP6NOVARTIS AG·Filed 2017·Granted Jun 16, 2020·2 cites·20 claims
- 0476US9296826B2Antibodies and methods for WNT pathway-related diseasesCONG FENG·Filed 2012·Granted Mar 29, 2016·5 cites·10 claims
- 0572US11434269B2Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)NOVARTIS AG·Filed 2017·Granted Sep 6, 2022·1 cites·25 claims
- 0669US9428583B2Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodiesCONG FENG·Filed 2011·Granted Aug 30, 2016·1 cites·52 claims
- 0768US8673306B2Compositions and methods of use for antibodies of dickkopf-1SHULOK JANINE·Filed 2007·Granted Mar 18, 2014·2 cites·11 claims
- 0865US11530261B2Compositions and methods for antibodies targeting BMP6NOVARTIS AG·Filed 2020·Granted Dec 20, 2022·0 cites·30 claims
- 0962US9296813B2Compositions and methods of use for antibodies of Dickkopf-1SHULOK JANINE R·Filed 2014·Granted Mar 29, 2016·1 cites·19 claims
- 1059US2020377603A1Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodiesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1154US2019203301A1Cancer patient selection for administration of wnt signaling inhibitors using rnf43 mutation statusNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1251US2015125857A1CANCER PATIENT SELECTION FOR ADMINISTRATION OF Wnt SIGNALING INHIBITORS USING RNF43 MUTATION STATUSNOVARTIS AG·Filed 2013·Application pending·0 cites
- 1350US2017362326A1Compositions and Methods of Use for Therapeutic Low Density Lipoprotein-related protein 6 (LRP6) AntibodiesNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1449US2010254980A1Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)NOVARTIS AG·Filed 2008·Application pending·0 cites
- 1548US2010267626A1Methods and compositions for measuring wnt activation and for treating wnt-related cancersNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1648US2017306409A1Cancer patient selection for administration of wnt signaling inhibitors using rnf43 mutation statusNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1747US2014341901A1Compositions and methods of use for antibodies of dickkopf-1SHULOK JANINE R·Filed 2014·Application pending·0 cites
- 1839US2018066067A1Antibodies and methods for wnt pathway-related diseasesCONG FENG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Feng Cong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →